dna-am.co.jp

DNA先端医療株式会社 is a pioneering Japanese company dedicated to advancing the accessibility and awareness of non-invasive prenatal testing (NIPT). Established on July 4, 2018, and located in Ebisu Prime Square Tower, Tokyo, the company focuses on providing comprehensive services related to genetic and genomic analysis. NIPT is a cutting-edge screening method that analyzes tiny fragments of fetal DNA found in a pregnant woman's bloodstream, enabling the assessment of chromosomal abnormalities without the risk of miscarriage associated with traditional invasive methods.

Unlike countries like the UK and the US, where prenatal screening is widely accepted, Japan has seen only about 1% of pregnant women undertake NIPT due to healthcare restrictions. DNA先端医療株式会社 is committed to ensuring that all expecting mothers have the opportunity to access this crucial testing. The company also offers educational resources through columns and comics to inform and engage the community about prenatal health.

With a partnership with Illumina, they are at the forefront of prenatal diagnostics in Japan